Skip to main content
Premium Trial:

Request an Annual Quote

Pronota Raises $1.9M in Series B Financing

NEW YORK (GenomeWeb News) – Belgian biomarker company Pronota said today that it has raised an additional €1.3 million ($1.9 million) in Series B financing from MP Healthcare Venture Management.

Pronota plans to use the funding from the venture company, which is a jointly owned subsidiary of Mitsubishi Tanabe Pharma and Mitsubishi Chemical Holdings, to develop its lead program in acute heart failure diagnostics toward full clinical proof of concept.

The firm said that results so far for its acute heart failure and other protein-based biomarker programs have validated its technology, and it expects to have its first product ready to roll out in early 2012.

This past summer, Pronota had raised €4.9 million in the Series B financing. Earlier participants in the round included LSP, Gimv, Biotech Fund Flanders, KBC Private Equity, Johnson & Johnson Development, and Baekeland Fund. Another investor, VIB, is a non-profit scientific research institute that developed the technology upon which Pronota's MASStermind platform is based.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.